Article Text

PDF
AB0915 A Low-Penetrance NLRP3 Variant in A NOD2 Carrier Possibly Worsens The Phenotype of Blau Syndrome
  1. P. Galozzi1,
  2. P. Sfriso1,
  3. D. Basso2,
  4. A. Scanu1,
  5. F. Oliviero1,
  6. M. Plebani2,
  7. L. Punzi1
  1. 1Rheumatology Unit, Dept. of Medicine
  2. 2Laboratory Medicine, Dept. of Medicine, University of Padova, Padova, Italy

Abstract

Background Blau syndrome (BS) is a rare autosomal dominant autoinflammatory syndrome that primarily affects skin, joints, and eyes, with varying severity of inflammation, and results from mutations in the NOD2 gene1. NOD2 bears highly conserved residues and structural similarities to the NLRP3 protein, a key component of the inflammasome which mutations underlie some autoinflammatory disorders, named cryopyrinopathies.

Objectives This study assessed the potential contribution of NLRP3 mutations to the inflammatory BS phenotype in an Italian affected family carrying p.E383K NOD2 mutation (Fig. 1).

Methods Genomic DNA was isolated from blood samples of the four affected family members and sequence analyses of NLRP3 were performed by an ABI 3730XL DNA sequencer (Applied Biosystems). A genotype/phenotype correlation of the carriers of NLRP3 variations was also assessed.

To explain the differences in inflammatory phenotype severity, peripheral blood mononuclear cells (PBMC) were isolated from patients and healthy subjects and their ability to activate NF-κB and inflammasome pathways was measured by an array-based assay (reverse phase protein array).

Results A heterozygous genetic variant of NLRP3 was found only in the proband's sample. The p.V198M mutation was known in literature as a low-penetrance mutation associated with cryopyrinopathies in symptomatic patients (Infevers database data). The proband with combined mutations presented the worsened BS phenotype (severe chronic bilateral uveitis with glaucoma, cataracts and visual impairment), whereas the three subjects with only p.E383K variant had a much milder disease.

Concerning the activation of NF-κB pathway, all BS patients have raised levels of signalling key molecules (phosphorylated NF-κB p<0.05; phosphorylated IkB-α p<0.05) compared to the controls. However, the components of inflammasome pathway presented a pattern of activation related to individual patients rather than to the whole disease. Enhanced level of cleaved caspase-1, the key component of inflammasome, was noticed only in proband PBMCs (p=0.03), potentially promoted by the additional presence of p.V198M NLRP3 mutation.

Conclusions Our data strongly suggest that severe phenotype in BS may result from co-existence with mutations in genes associated with other autoinflammatory diseases, and are consistent with recently reported findings in hereditary periodic fever syndromes2. The synergistic effect of dual mutations can also explain the differential activation of the inflammatory pathways and may lead to appropriate targeted drug development.

  1. Sfriso P, Autoimm Rev. 2012

  2. Touitou I, J Med Genet. 2013

Disclosure of Interest None declared

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.